Peanut Allergy Market: Global Market Growth by Product Type, Therapy, Distribution Channel, End-Use and Region Forecast (2024 – 2030)

Global Peanut Allergy Market expected to hit USD 40.84 Bn by 2030 from USD 0.22 Bn in 2023 at a CAGR of 110% during the forecast period

Peanut Allergy Market Overview

Peanut Allergy is considered one of the most common causes of allergy attacks, which sometimes can be life-threatening. The peanut allergy is expected to occur through direct contact, cross-contact and inhalation of dust and aerosols containing peanuts. Children and adults are most exposed to the peanut allergy. The growing concerns regarding allergies in this age group are expected to drive the Peanut Allergy Market.Peanut Allergy MarketTo know about the Research Methodology :- Request Free Sample Report

Peanut Allergy Market Dynamics

Market Drivers The growing rate of peanut allergy in the children and geriatric population is expected to drive the Peanut Allergy Market. It becomes a major concern for families across the world since the MMR study reports that approximately 2 percent of the population is affected and allergy depends on how much peanut protein was consumed during infancy. The Learning Early about Peanut Allergy (LEAP) study tries to minimize peanut allergies in children by introducing peanuts to infants. The Peanut Allergy Market is also driven by carrying out a peanut allergy action plan for specific symptoms, if symptoms are mild such as swelling then Benadryl or Zyrtec is used and if symptoms are serious such as trouble breathing, wheezing, throat swelling, vomiting, diarrhea, dizziness then epinephrine must be used. The Continuous increase in cases of peanut allergies all over the world is creating a lucrative opportunity for Peanut Allergy Key Players in the global Peanut Allergy Industry. Also, the continuous investment by Peanut Allergy Key Companies in research and development to launch new medicines for Peanut Allergy Treatments is expected to boost the Peanut Allergy Market. Allergen Research Corporation (ARC) now known as Aimmune Therapeutics has raised USD 80 million to tackle the problem of peanut allergies through their research. This is expected to drive the Peanut Allergy Market. The company is working on developing a product that desensitizes patients so that accidental exposure to peanuts doesn't cause a severe allergic response.

Peanut Allergy Market Trends

Epicutaneous peanut immunotherapy: Epicutaneous peanut immunotherapy is a patch that delivers peanut protein into the skin but has to stay on for up to 24 hours a day. Epicutaneous peanut immunotherapy (EPIT) is promising the treatment of peanut allergy in children and young adults, which avoids life-threatening allergic reactions. The efficacy of this treatment increased to 51.8 percent and is expected to drive the Peanut Allergy Market. Epicutaneous peanut immunotherapy lowers the risk of allergic reactions and is easy to use. Oral peanut immunotherapy: Oral immunotherapy with peanut protein has been performed for decades in selected patients at allergy centers including both low and higher doses of peanut protein. The efficacy of oral peanut immunotherapy is high and most of the patients achieved desensitization. This is propelling the growth of the Peanut Allergy Market. The OIT helps desensitize patients to the food they are allergic to by giving them small quantities of the food allergen to ingest every day and gradually building their body’s resistance to the allergic food. Sublingual peanut immunotherapy: Sublingual peanut immunotherapy refers to repeatedly exposing patients to small doses of allergen to make them less sensitive to it. This repeated exposure to small but increasing doses of allergen desensitizes patients’ immune systems and the body becomes tolerant of the allergen and cures the allergy of a patient. This is a popular form of therapy for Peanut Allergy Treatment and is expected to grow significantly in the Peanut Allergy Market. Use of biologics to treat peanut allergy: The biological agent that has been the longest in use in the field of allergies is anti-IgE, which has been approved for the treatment of allergies. Peanut allergy continues to pose problems due to its increased frequency and its increasingly high severity. These multiple types of immunotherapies are expected to drive the Peanut Allergy Market.

Market Restraints

The report has used primary and secondary research methods to collect the Peanut Allergy Industry Data and analyses that data through SWOT analysis and PORTER’s five force model, which includes Peanut Allergy Market Growth drivers, opportunities, restraints and regional insights. The high price associated with the drugs for Peanut Allergy Treatment is expected to hamper the growth of the Peanut Allergy Market. Also, the lack of awareness regarding allergies to such small ingredients and the treatments such as oral immunotherapy is expected to reduce the severity of allergy but needs a lengthy intervention with no known standardized methodology, which is expected to impede the growth of the Peanut Allergy Market.

Regional Insights

North America held the largest share of the Peanut Allergy Market in 2023 since peanut allergy is one of the eight most common food allergies that affects nearly 2 percent of the United States population. Canada is also one of the North American countries with the highest prevalence of peanut allergies. The continuous research and developments in the Peanut Allergy Industry by major Peanut Allergy Key Players has been driving the regions market growth. One of the major reason that North Americans allergic to peanuts is due to their genetics. The region is emerged as a lucrative opportunity for Peanut Allergy Key Companies to increase their Peanut Allergy Market Share. After North America, Europe is expected to grow at the highest rate during the forecast period (2024-2030) in Peanut Allergy Market. Recently, on January 5, 2021, European Commission approved PALFORZIA for the treatment of peanut allergy. PALFORZIA is a complex biologic drug used with a structured dosing approach that builds on a century of oral immunotherapy (OIT) research. With OIT, the specific allergenic proteins are ingested initially in very small quantities, followed by incrementally increasing amounts that later improves the ability of patient to specific allergen. The treatment is expected to spread relief to millions of people in the region living with life-threatening peanut allergy. UK agencies are urging for testing of soy product from India because of peanut allergy risk. This is because there has been widespread contamination of the food additive with undeclared peanut protein at different levels over some time, posing a risk to people with peanut allergies. All these factors are expected to drive the Europe Peanut Allergy Market. Asia Pacific is expected to hold the largest share in the Market despite the allergy is not as prevalent in Western countries. The report states that 0.67 percent in Korean infants, 0.47 to 0.64 percent in Singaporean children, 0.43 percent in Filipino children, 05. To 1.1 percent in Taiwan and almost no cases of peanut allergy in China and Thailand. These are half of the western countries. But the trial conducted in the Australia denotes that children aged six to eighteen have peanut allergies. The Asia Pacific Peanut Allergy Industry growth is supported by the above factors mentioned.

Competitive Landscape

The report provides a detailed data regarding competitive landscape through key players Peanut Allergy Market Size, Peanut Allergy Market Share and Peanut Allergy Market Revenue. The report includes a data about recent developments, Market Penetration, mergers and acquisitions by the major Peanut Allergy Key Companies. Recently, on May 28, 2020, Aimmune Therapeutics, Inc, a biopharmaceutical company developing and commercializing treatments for life-threatening food allergies announced that findings from APPEAL-1 (Allergy to Peanuts ImPacting Emotions And Life-1), a multi-dimensional pan-European study assessing the psychosocial effect and impact of living with peanut allergy, were published in Allergy, one of the official journals of European Academy of Allergy and Clinical Immunology (EAACI). The study, published in two parts (Part A and Part B), highlights the substantial impact peanut allergy has on every aspect of allergic individuals’ and their caregivers’ lives, including the uncertainty they feel around how to manage frightening and debilitating reactions and concerns about the feasibility of ongoing avoidance. The organization not only focusing on just physical aspect of the peanut allergy but on social and psychological impact on the humans. This is expected to drive the Market. DBV Technologies, Sanofi, Vedanta Biosciences Inc, Alladapt Immunotherapeutics, Inc., InnoUp and Cambridge Allergy Ltd. are some of the major Peanut Allergy Key Players.

Peanut Allergy Market Segment Analysis

Based on Product Type The research proved that liquid dosage in the treatment of any allergy have early relief. The liquid dosage segment held the largest revenue share in the Peanut Allergy Market. Liquid dosage are easily digest and started showing results. The ingredients such as adsorbents and antacids deliver more intense effects, when taken in liquid forms. Measurement of different volume can easily and conveniently adjust the dose of the substance. Liquid dosages are in sweetened, colored and flavored forms to deliver bitter and unpleasant medicines. Whereas, solid dosages are difficult to consume and took time to digest in blood to show the results. These factors are expected to boost the liquid dosage segment in Peanut Allergy Market. Based on End-Use Hospitals are demanding for the drugs and medicines used in the cure of peanut allergy since the allergic patients mostly visits hospital when symptoms shown due to its life-threatening effects. Hence, the hospital segment held the largest share of the Market. The increased expenditure on healthcare sector across the world and the launch of innovative technologies in the medical field has been driving the segment to grow significantly during the forecast period.

Peanut Allergy Market Scope: Inquire before buying

Peanut Allergy Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: USD 0.22 Bn
Forecast Period 2024 to 2030 CAGR: 110% Market Size in 2030: USD 40.84 Bn
Segments Covered: by Product Type Solid Dosage Form Liquid Dosage Form
by Therapy Epicutaneous peanut immunotherapy Oral peanut immunotherapy Sublingual peanut immunotherapy Use of biologics
by Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
by End-Use Hospitals Home Care Settings Clinics

Peanut Allergy Market, by Region:

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Peanut Allergy Key Players include:

1. DBV Technologies 2. Sanofi 3. Vedanta Biosciences Inc 4. Alladapt Immunotherapeutics, Inc. 5. InnoUp 6. Cambridge Allergy Ltd. 7. COUR Pharmaceuticals 8. Regeneron Pharmaceuticals Inc. 9. Aimmune Therapeutics 10. Moonlight Therapeutics 11. Prota Therapeutics 12. Intrommune Therapeutics 13. Blue Willow Biologics 14. Aravax Pty Ltd. Frequently Asked Questions: 1] What is the growth rate of the Peanut Allergy Market? Ans. The Market is growing at a CAGR of 110% during the forecast period. 2] Which region is expected to dominate the Peanut Allergy Market? Ans. North America is expected to dominate the Peanut Allergy Market during the forecast period from 2024 to 2030. 3] What is the expected Peanut Allergy Market size by 2030? Ans. The size of the Peanut Allergy Market by 2030 is expected to reach USD 40.84 Bn. 4] Who are the top players in the Market? Ans. The major key players in the Market are DBV Technologies, Sanofi, Vedanta Biosciences Inc and Alladapt Immunotherapeutics, Inc. 5] Which factors contributed to the growth of the Peanut Allergy Market in 2023? Ans. The Peanut Allergy Market is expected to grow due to the rising prevalence of peanut allergies across the world.
1. Peanut Allergy Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Peanut Allergy Market: Dynamics 2.1. Peanut Allergy Market Trends by Region 2.1.1. North America Peanut Allergy Market Trends 2.1.2. Europe Peanut Allergy Market Trends 2.1.3. Asia Pacific Peanut Allergy Market Trends 2.1.4. Middle East and Africa Peanut Allergy Market Trends 2.1.5. South America Peanut Allergy Market Trends 2.2. Peanut Allergy Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Peanut Allergy Market Drivers 2.2.1.2. North America Peanut Allergy Market Restraints 2.2.1.3. North America Peanut Allergy Market Opportunities 2.2.1.4. North America Peanut Allergy Market Challenges 2.2.2. Europe 2.2.2.1. Europe Peanut Allergy Market Drivers 2.2.2.2. Europe Peanut Allergy Market Restraints 2.2.2.3. Europe Peanut Allergy Market Opportunities 2.2.2.4. Europe Peanut Allergy Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Peanut Allergy Market Drivers 2.2.3.2. Asia Pacific Peanut Allergy Market Restraints 2.2.3.3. Asia Pacific Peanut Allergy Market Opportunities 2.2.3.4. Asia Pacific Peanut Allergy Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Peanut Allergy Market Drivers 2.2.4.2. Middle East and Africa Peanut Allergy Market Restraints 2.2.4.3. Middle East and Africa Peanut Allergy Market Opportunities 2.2.4.4. Middle East and Africa Peanut Allergy Market Challenges 2.2.5. South America 2.2.5.1. South America Peanut Allergy Market Drivers 2.2.5.2. South America Peanut Allergy Market Restraints 2.2.5.3. South America Peanut Allergy Market Opportunities 2.2.5.4. South America Peanut Allergy Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Peanut Allergy Industry 2.8. Analysis of Government Schemes and Initiatives For Peanut Allergy Industry 2.9. Peanut Allergy Market Trade Analysis 2.10. The Global Pandemic Impact on Peanut Allergy Market 3. Peanut Allergy Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 3.1.1. Solid Dosage Form 3.1.2. Liquid Dosage Form 3.2. Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 3.2.1. Epicutaneous peanut immunotherapy 3.2.2. Oral peanut immunotherapy 3.2.3. Sublingual peanut immunotherapy 3.2.4. Use of biologics 3.3. Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 3.3.1. Hospital Pharmacies 3.3.2. Retail Pharmacies 3.3.3. Online Pharmacies 3.4. Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 3.4.1. Hospitals 3.4.2. Home Care Settings 3.4.3. Clinics 3.5. Peanut Allergy Market Size and Forecast, by Region (2023-2030) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Peanut Allergy Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 4.1.1. Solid Dosage Form 4.1.2. Liquid Dosage Form 4.2. North America Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 4.2.1. Epicutaneous peanut immunotherapy 4.2.2. Oral peanut immunotherapy 4.2.3. Sublingual peanut immunotherapy 4.2.4. Use of biologics 4.3. North America Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 4.3.1. Hospital Pharmacies 4.3.2. Retail Pharmacies 4.3.3. Online Pharmacies 4.4. North America Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 4.4.1. Hospitals 4.4.2. Home Care Settings 4.4.3. Clinics 4.5. North America Peanut Allergy Market Size and Forecast, by Country (2023-2030) 4.5.1. United States 4.5.1.1. United States Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 4.5.1.1.1. Solid Dosage Form 4.5.1.1.2. Liquid Dosage Form 4.5.1.2. United States Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 4.5.1.2.1. Epicutaneous peanut immunotherapy 4.5.1.2.2. Oral peanut immunotherapy 4.5.1.2.3. Sublingual peanut immunotherapy 4.5.1.2.4. Use of biologics 4.5.1.3. United States Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 4.5.1.3.1. Hospital Pharmacies 4.5.1.3.2. Retail Pharmacies 4.5.1.3.3. Online Pharmacies 4.5.1.4. United States Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 4.5.1.4.1. Hospitals 4.5.1.4.2. Home Care Settings 4.5.1.4.3. Clinics 4.5.2. Canada 4.5.2.1. Canada Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 4.5.2.1.1. Solid Dosage Form 4.5.2.1.2. Liquid Dosage Form 4.5.2.2. Canada Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 4.5.2.2.1. Epicutaneous peanut immunotherapy 4.5.2.2.2. Oral peanut immunotherapy 4.5.2.2.3. Sublingual peanut immunotherapy 4.5.2.2.4. Use of biologics 4.5.2.3. Canada Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 4.5.2.3.1. Hospital Pharmacies 4.5.2.3.2. Retail Pharmacies 4.5.2.3.3. Online Pharmacies 4.5.2.4. Canada Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 4.5.2.4.1. Hospitals 4.5.2.4.2. Home Care Settings 4.5.2.4.3. Clinics 4.5.3. Mexico 4.5.3.1. Mexico Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 4.5.3.1.1. Solid Dosage Form 4.5.3.1.2. Liquid Dosage Form 4.5.3.2. Mexico Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 4.5.3.2.1. Epicutaneous peanut immunotherapy 4.5.3.2.2. Oral peanut immunotherapy 4.5.3.2.3. Sublingual peanut immunotherapy 4.5.3.2.4. Use of biologics 4.5.3.3. Mexico Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 4.5.3.3.1. Hospital Pharmacies 4.5.3.3.2. Retail Pharmacies 4.5.3.3.3. Online Pharmacies 4.5.3.4. Mexico Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 4.5.3.4.1. Hospitals 4.5.3.4.2. Home Care Settings 4.5.3.4.3. Clinics 5. Europe Peanut Allergy Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 5.1. Europe Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 5.1. Europe Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 5.1. Europe Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 5.5. Europe Peanut Allergy Market Size and Forecast, by Country (2023-2030) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 5.5.1.2. United Kingdom Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 5.5.1.3. United Kingdom Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.1.4. United Kingdom Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 5.5.2. France 5.5.2.1. France Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 5.5.2.2. France Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 5.5.2.3. France Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.2.4. France Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 5.5.3. Germany 5.5.3.1. Germany Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 5.5.3.2. Germany Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 5.5.3.3. Germany Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.3.4. Germany Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 5.5.4. Italy 5.5.4.1. Italy Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 5.5.4.2. Italy Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 5.5.4.3. Italy Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.4.4. Italy Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 5.5.5. Spain 5.5.5.1. Spain Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 5.5.5.2. Spain Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 5.5.5.3. Spain Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.5.4. Spain Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 5.5.6. Sweden 5.5.6.1. Sweden Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 5.5.6.2. Sweden Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 5.5.6.3. Sweden Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.6.4. Sweden Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 5.5.7. Austria 5.5.7.1. Austria Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 5.5.7.2. Austria Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 5.5.7.3. Austria Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.7.4. Austria Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 5.5.8.2. Rest of Europe Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 5.5.8.3. Rest of Europe Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.8.4. Rest of Europe Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6. Asia Pacific Peanut Allergy Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.2. Asia Pacific Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.3. Asia Pacific Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.4. Asia Pacific Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6.5. Asia Pacific Peanut Allergy Market Size and Forecast, by Country (2023-2030) 6.5.1. China 6.5.1.1. China Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.5.1.2. China Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.5.1.3. China Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.1.4. China Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6.5.2. S Korea 6.5.2.1. S Korea Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.5.2.2. S Korea Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.5.2.3. S Korea Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.2.4. S Korea Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6.5.3. Japan 6.5.3.1. Japan Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.5.3.2. Japan Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.5.3.3. Japan Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.3.4. Japan Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6.5.4. India 6.5.4.1. India Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.5.4.2. India Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.5.4.3. India Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.4.4. India Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6.5.5. Australia 6.5.5.1. Australia Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.5.5.2. Australia Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.5.5.3. Australia Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.5.4. Australia Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6.5.6. Indonesia 6.5.6.1. Indonesia Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.5.6.2. Indonesia Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.5.6.3. Indonesia Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.6.4. Indonesia Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6.5.7. Malaysia 6.5.7.1. Malaysia Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.5.7.2. Malaysia Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.5.7.3. Malaysia Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.7.4. Malaysia Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6.5.8. Vietnam 6.5.8.1. Vietnam Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.5.8.2. Vietnam Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.5.8.3. Vietnam Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.8.4. Vietnam Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6.5.9. Taiwan 6.5.9.1. Taiwan Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.5.9.2. Taiwan Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.5.9.3. Taiwan Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.9.4. Taiwan Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 6.5.10.2. Rest of Asia Pacific Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 6.5.10.3. Rest of Asia Pacific Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.10.4. Rest of Asia Pacific Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 7. Middle East and Africa Peanut Allergy Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 7.2. Middle East and Africa Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 7.3. Middle East and Africa Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 7.4. Middle East and Africa Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 7.5. Middle East and Africa Peanut Allergy Market Size and Forecast, by Country (2023-2030) 7.5.1. South Africa 7.5.1.1. South Africa Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 7.5.1.2. South Africa Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 7.5.1.3. South Africa Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 7.5.1.4. South Africa Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 7.5.2. GCC 7.5.2.1. GCC Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 7.5.2.2. GCC Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 7.5.2.3. GCC Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 7.5.2.4. GCC Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 7.5.3. Nigeria 7.5.3.1. Nigeria Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 7.5.3.2. Nigeria Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 7.5.3.3. Nigeria Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 7.5.3.4. Nigeria Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 7.5.4.2. Rest of ME&A Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 7.5.4.3. Rest of ME&A Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 7.5.4.4. Rest of ME&A Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 8. South America Peanut Allergy Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 8.2. South America Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 8.3. South America Peanut Allergy Market Size and Forecast, by Distribution Channel(2023-2030) 8.4. South America Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 8.5. South America Peanut Allergy Market Size and Forecast, by Country (2023-2030) 8.5.1. Brazil 8.5.1.1. Brazil Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 8.5.1.2. Brazil Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 8.5.1.3. Brazil Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 8.5.1.4. Brazil Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 8.5.2. Argentina 8.5.2.1. Argentina Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 8.5.2.2. Argentina Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 8.5.2.3. Argentina Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 8.5.2.4. Argentina Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Peanut Allergy Market Size and Forecast, by Product Type (2023-2030) 8.5.3.2. Rest Of South America Peanut Allergy Market Size and Forecast, by Therapy (2023-2030) 8.5.3.3. Rest Of South America Peanut Allergy Market Size and Forecast, by Distribution Channel (2023-2030) 8.5.3.4. Rest Of South America Peanut Allergy Market Size and Forecast, by End-User (2023-2030) 9. Global Peanut Allergy Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Peanut Allergy Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. DBV Technologies 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Sanofi 10.3. Vedanta Biosciences Inc 10.4. Alladapt Immunotherapeutics, Inc. 10.5. InnoUp 10.6. Cambridge Allergy Ltd. 10.7. COUR Pharmaceuticals 10.8. Regeneron Pharmaceuticals Inc. 10.9. Aimmune Therapeutics 10.10. Moonlight Therapeutics 10.11. Prota Therapeutics 10.12. Intrommune Therapeutics 10.13. Blue Willow Biologics 10.14. Aravax Pty Ltd. 11. Key Findings 12. Industry Recommendations 13. Peanut Allergy Market: Research Methodology 14. Terms and Glossary
  • INQUIRE BEFORE BUYING